Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Lim
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
325 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
- Sutter Auburn Faith Hospital
Auburn, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Kaiser Permanente Dublin
Dublin, California, United States
- Kaiser Permanente-Fremont
Fremont, California, United States
- Kaiser Permanente Fresno Orchard Plaza
Fresno, California, United States
- Uci Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- City of Hope at Long Beach Elm
Long Beach, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente- Modesto Mob Ii
Modesto, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Uc Irvine Health/chao Family Comprehensive Cancer Center
Orange, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Stanford Cancer Institute Palo Alto
Palo Alto, California, United States
- Kaiser Permanente- Marshall Medical Offices
Redwood City, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Sutter Roseville Medical Center
Roseville, California, United States
- Kaiser Permanente Downtown Commons
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Kaiser Permanente San Leandro
San Leandro, California, United States
- Kaiser San Rafael-Gallinas
San Rafael, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
- Kaiser Permanente-Santa Rosa
Santa Rosa, California, United States
- Kaiser Permanente-South San Francisco
South San Francisco, California, United States
- City of Hope Upland
Upland, California, United States
- Kaiser Permanente-Vallejo
Vallejo, California, United States
- John Muir Medical Center-Walnut Creek
Walnut Creek, California, United States
- Kaiser Permanente-Walnut Creek
Walnut Creek, California, United States
- Memorial Hospital North
Colorado Springs, Colorado, United States
- Uchealth Memorial Hospital Central
Colorado Springs, Colorado, United States
- Kaiser Permanente-Franklin
Denver, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Nov 2024
- Primary completion
- 15 Jul 2028
- Completion
- 15 Jul 2028
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 184
- Registry id
- NCT06325683
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.